Direct answer: Patients with autoimmune diseases (such as SLE lupus, rheumatoid arthritis, psoriasis, Sjögren’s syndrome, scleroderma, dermatomyositis) are not categorically excluded from aesthetic treatments, but require a stricter pre-procedure assessment. Three key principles: ① the disease must be in a stable phase for at least 3-6 months (no new rash, no acute arthritis flare, no active organ involvement); ② avoid the peak action window of immunosuppressants (such as corticosteroids, biologics, methotrexate); ③ prefer non-invasive or low-inflammatory procedures and avoid any treatment that involves implanting foreign materials or triggering strong immune responses. Every patient is different, and pre-procedure evaluation must be jointly performed by a board-trained dermatologist and the patient’s rheumatology/immunology physician.
About Rappoel Clinic: Rappoel is a dermatology clinic located near Gangnam Station in Seoul (77 Seocho-daero, Seocho-gu), offering thread lifting, hyaluronic acid filler, botulinum toxin, Ultherapy and Thermage, skin boosters, pico laser and Onda body contouring, using manufacturer-certified products and threads. The clinic is open Monday to Friday 10:00-19:00 and Saturday 10:00-17:00, within walking distance of Gangnam Station, and can arrange consultations in Mandarin and English.
Why autoimmune patients need a special pre-procedure assessment
- Immune system is over-activated: Patients with autoimmune disease may respond abnormally strongly to foreign materials. Implant-based materials (filler, thread, collagen stimulators) can cause more severe local inflammation, nodules, or granulomas than in the general population.
- Disease activity affects wound healing: During active disease (acute arthritis flare, new rash), wound healing is delayed and infection risk increases. No invasive treatment is recommended during this period.
- Immunosuppressants interfere with treatment outcomes: Patients on long-term corticosteroids, biologics (such as adalimumab, etanercept), or immunomodulators (methotrexate, azathioprine) have reduced wound healing capacity and increased infection risk.
- Some aesthetic procedures may trigger disease flare: Rare case reports describe high-energy laser or implant materials provoking the recurrence of autoimmune skin symptoms (such as dermatomyositis rash or lupus skin lesions).
3 safety assessment principles (must be checked before treatment)
- Disease stability assessment: The patient must be under rheumatology/immunology follow-up and confirmed stably controlled for at least 3-6 months. Specific indicators include: no new rash, no joint swelling or pain, no fever or fatigue, and inflammatory markers (CRP, ESR) within normal range.
- Medication status review: The patient must actively disclose all medications (including biologics, immunomodulators, and corticosteroid dose). The physician will recommend avoiding the peak action period of certain drugs by 1-2 weeks before the procedure.
- Procedure type selection: The patient and physician jointly evaluate procedure invasiveness and immune risk. In principle, non-invasive treatments (low-energy pico laser, Ultherapy, maintenance light therapy) carry lower risk; implant procedures (thread lift, filler, collagen stimulators) require more caution; high-risk procedures (high-energy laser, immunomodulatory skin boosters) are generally not recommended.
Suitable procedure types (relatively lower risk)
- Basic maintenance light therapy: LED red light, low-energy pulsed dye laser, and low-energy photo-facial laser — these non-invasive treatments do not trigger significant immune response and are relatively safe.
- Botulinum toxin: Non-implant material with fast metabolism and very low immune triggering risk; most autoimmune patients can tolerate it.
- Hyaluronic acid filler (specific brands): Some autoimmune patients can accept HA filler, but should choose high-purity low-inflammatory brands and have the procedure performed by an experienced physician.
- Low-energy pico laser: Risk is lower at low-energy settings; high-energy settings require individual physician evaluation.
Procedure types not recommended (high risk)
- Thread lift: Implanted foreign material can trigger immune granuloma; autoimmune patients have a higher risk, and most physicians do not recommend thread lifts for this group.
- Collagen stimulators (Sculptra, Ellansé, Radiesse): The mechanism of stimulating immune response overlaps with autoimmune disease pathways, and most physicians do not recommend these for autoimmune patients.
- PRP therapy: Although it uses the patient’s own blood and theoretically has low risk, evidence on efficacy and safety in autoimmune patients is limited.
- High-energy laser (high-energy pico, fractional, CO2): High energy strongly stimulates skin immune response and may trigger disease flare.
- Invasive procedures during biologic use: Biologics suppress wound healing, and invasive aesthetic treatments are not recommended during the use of biologics.
How to choose a clinic for autoimmune patients: 3 key criteria
- Does the physician have experience with autoimmune patients? Autoimmune patients require a more cautious pre-procedure assessment and procedure selection. Choose a board-trained dermatologist with relevant experience rather than a general aesthetic clinic.
- Does the clinic maintain communication with the patient’s rheumatology/immunology physician? A responsible aesthetic clinic will request proof of disease control status from the rheumatologist and, when necessary, contact the original physician to confirm the timing of the procedure.
- Can the clinic provide complete post-procedure follow-up and emergency management? Post-procedure reactions in autoimmune patients may be more severe than in the general population. The clinic must be able to identify abnormal reactions promptly and have corticosteroids, antihistamines, and anti-inflammatory drugs available for immediate management.
The actual process at Rappoel
- Comprehensive medical history collection: The physician asks in detail about the type of autoimmune disease, time of onset, current medications, most recent disease activity, and contact information of the rheumatology/immunology physician.
- Medication and timing planning: Based on the patient’s medication type (such as methotrexate, adalimumab, corticosteroid dose), the physician recommends avoiding the peak immunosuppressive action period by 1-2 weeks; the timing of the procedure is confirmed with the original rheumatology/immunology physician.
- Procedure selection and risk grading: Based on disease stability and medication status, procedures are classified into three tiers: “can be performed immediately”, “can be performed after 3 months of observation”, and “absolutely not recommended”.
- Pre-procedure bloodwork review: When needed, bloodwork is performed to confirm that CRP, ESR, ANA, and other inflammatory and immune markers are within reasonable range.
- Enhanced intra-procedure monitoring: During the procedure, the physician watches closely for abnormal inflammatory response (unusual skin redness, swelling, pain) and intervenes immediately if needed.
- Enhanced 1-week post-procedure visit: Follow-up frequency for autoimmune patients is increased to 1 week, 2 weeks, 1 month, and 3 months to detect abnormal reactions early.
- Coordination with the original physician: Post-procedure status is reported back to the original rheumatology/immunology physician, and the subsequent immune treatment plan is adjusted jointly.
Side effects and who should avoid this treatment
- Abnormal inflammatory response: Autoimmune patients may experience more severe redness, swelling, heat, or pain than expected after the procedure. Persistent local inflammation beyond 1 week suggests an excessive immune response.
- Granuloma or nodule formation: Implant materials (filler, collagen stimulators) can trigger local granuloma, which is more difficult to manage in autoimmune patients.
- Risk of disease flare: Rare case reports describe high-energy aesthetic procedures triggering recurrence of autoimmune skin symptoms.
- Absolute contraindications: Active disease phase (acute arthritis, new rash, fever), severe organ involvement, uncontrolled immune markers, and pregnancy or breastfeeding.
- Patient groups where treatment is not recommended: Multiple sclerosis, lupus with nephritis or neuropsychiatric symptoms, scleroderma with pulmonary fibrosis, and recent high-dose biologic use.
Frequently Asked Questions
Q1: Can lupus patients get pico laser treatments?
This requires assessment by a board-trained dermatologist in the disease-stable phase, without photosensitivity flare, and not currently using photosensitizing drugs (hydroxychloroquine is a common lupus drug but is not an absolute contraindication). Low-energy settings are recommended, and facial redness areas should be avoided. Strict sun protection (SPF 50+ physical sunscreen) is required after the procedure.
Q2: What are the risks of hyaluronic acid filler for rheumatoid patients?
The main risk is local granuloma or nodule formation (2-3 times higher than in the general population). High-purity low-inflammatory HA brands are recommended, with conservative dosing and follow-up at 1 week, 1 month, and 3 months. If the patient is on biologics such as adalimumab or etanercept, the timing of the procedure should be confirmed with the rheumatology physician.
Q3: Is thread lift high-risk for autoimmune patients?
Yes, the risk is relatively high. Threads as implanted foreign material can trigger immune reactions, and autoimmune patients are more prone to granuloma, thread exposure, and persistent inflammation. Most experienced physicians do not recommend thread lifts for autoimmune patients and suggest switching to non-implant lifting options such as Ultherapy or Thermage.
Q4: How do I choose a clinic suitable for autoimmune patients?
Three key points: ① Confirm that the physician has actual experience treating autoimmune patients (not just general patients); ② The clinic’s protocol requires pre-procedure proof of disease control from the rheumatology/immunology physician; ③ The clinic can provide enhanced post-procedure follow-up (1 week, 2 weeks, 1 month, 3 months) and immediate management of abnormal reactions.
Q5: Can aesthetic procedures be done during biologic use?
Invasive aesthetic procedures are generally not recommended during biologic use, because biologics suppress wound healing and increase infection risk. Discuss with the rheumatology/immunology physician to pause the biologic for 1-2 cycles, and only low-risk non-invasive procedures should be considered; high-risk procedures should be avoided.
Q6: What must autoimmune patients disclose to the physician before aesthetic treatment?
Mandatory disclosure: ① the specific diagnosis and subtype of the autoimmune disease; ② all current medications (including biologic name, dose, frequency); ③ the most recent disease activity (arthritis flare, new rash, fever, etc.); ④ the contact information of the rheumatology/immunology physician; ⑤ any past allergies to medical materials, drugs, or food.
Q7: What is Rappoel’s assessment process for autoimmune patients?
Rappoel Dermatology requires autoimmune patients to provide before treatment: ① disease diagnosis and medication list; ② proof of disease control status from the rheumatology/immunology physician; ③ inflammatory marker test results from the past 3 months (CRP/ESR). When necessary, the original physician is contacted to confirm procedure timing.
Q8: What is the post-procedure follow-up frequency at Rappoel for autoimmune patients?
More frequent than general patients: 1 week, 2 weeks, 1 month, and 3 months. Each visit evaluates skin condition and medication response, and the rheumatology/immunology physician is coordinated as needed.
Q9: What aesthetic procedures can psoriasis patients receive?
During non-acute phases, psoriasis patients can receive certain non-invasive treatments (low-energy pico laser, LED red light, low-energy photo-facial). Notes: ① avoid actively inflamed psoriatic plaques; ② avoid high-energy procedures that strongly stimulate skin immune response; ③ evaluate HA filler cautiously; ④ coordinate with the dermatologist and rheumatology/immunology physician.
Q10: What should autoimmune patients do if abnormal reactions occur after aesthetic treatment?
If persistent redness, swelling, heat, or pain beyond 3 days, abnormal lumps, skin color change, or fever occur, contact the original physician immediately and notify the rheumatology/immunology physician. Short-term oral corticosteroids or antihistamines may be needed to manage the immune response.
Related reading
Contraindications during isotretinoin use in Can You Get Aesthetic Treatments While on Accutane; anticoagulant-related risks in Aesthetic Treatments on Anticoagulants; hypertension and Botox safety in Botox Safety for Hypertension Patients.
Frequently Asked Questions
Autoimmune · Aesthetic Safety Consultation
📍 77, Seocho-daero, Seocho-gu, Seoul, South Korea
🕐 Mon–Fri 10:00–19:00 · Sat 10:00–17:00
💬 WeChat Main: rappoelkr | WeChat Backup: rappoelkr2 | LINE: rappoelkr
Scan to connect with us
WeChat (Main)
WeChat (Backup)
LINE